Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
| Conditions: | Breast Cancer|Colorectal Cancer|Head and Neck Cancer|Lung Cancer|Mesothelioma|Pancreatic Cancer|Prostate Cancer|Sarcoma |
| Start Date: | May 1, 2008 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00703638 |
| Study Type: | Interventional |
| Intervention: | Drug: cisplatin|Drug: pemetrexed disodium|Drug: sorafenib |
| Study Design: | Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Masonic Cancer Center, University of Minnesota |
| Ages: | Adult|Senior |
| Enrollment: | 16 |
| Funded By: | Other |
| First Received: | June 20, 2008 |
| End Date: | November 1, 2010 |
| Last Updated: | November 30, 2010 |
| Last Verified: | November 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
